[The effects of prolonged treatment with gliclazide on the course of proteinuria and renal function in diabetic nephropathy].
D003404:Creatinine / Q000097:blood; D003925:Diabetic Angiopathies / Q000188:drug therapy; D003928:Diabetic Nephropathies / Q000150:complications / Q000188:drug therapy*; D005260:Female; D005907:Gliclazide / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D007676:Kidney Failure, Chronic / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D008875:Middle Aged; D011507:Proteinuria / Q000188:drug therapy* / Q000209:etiology; D013453:Sulfonylurea Compounds / Q000008:administration & dosage*; D013997:Time Factors
D013453:Sulfonylurea Compounds; D003404:Creatinine; D005907:Gliclazide
Effets du gliclazide en traitement prolongé sur l'évolution de la protéinurie et de la fonction rénale au cours de la néphropathie diabétique.